Direct Genomics

company

About

Direct Genomics is providing physicians with the first single molecule sequencer built exclusively for the clinic.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$34.80M
Industries
Biotechnology,Commercial
Founded date
Jul 4, 2012
Number Of Employee
1 - 10
Operating Status
Active

Direct Genomics is making genomics an affordable part of everyday patient care. The company’s GenoCare instrument is the first single molecule sequencing system for clinical use. That simplifies sequencing by directly reading individual DNA and RNA molecule information from customer’s blood or tissue samples, delivering significant improvements in cost and speed. Established in 2012, Direct Genomics is headquartered in Shenzhen, China and backed by institutional and private investors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$34.80M
Direct Genomics has raised a total of $34.80M in funding over 2 rounds. Their latest funding was raised on Apr 19, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 19, 2018 Series A $34.80M 1 Cosun Venture Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Direct Genomics is funded by 1 investors. Cosun Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Cosun Venture Capital Yes Series A